NFKB1 and neoplasm: Because the manipulation of NF-κB signaling by KSHV gene products is well established, the relevance of this pathway to lymphomagenesis should be carefully addressed using non-heterologous systems, such as PEL tumor samples and patient derived xenografts, which is beyond the scope of this study.